semaglutide woodland hills GLP-1 for Weight Loss GLP-1 Treatments, Semaglutide Medical Weight

& Merrifield, R

Safety and long-term effects are still topics of scientific investigation

In summary, in this 26-week dose-finding study, oral semaglutide demonstrated robust efficacy for A1C reduction and weight loss, with the 20 mg and 40 mg once-daily doses of oral semaglutide producing similar glycemic and weight benefits when compared with injectable semaglutide

GLP-1 drugs approved by the Food and Drug Administration (FDA) include semaglutide (brand names Wegovy, Ozempic and Rybelsus), tirzepatide (brand names Zepbound and Mounjaro) and liraglutide (brand name Saxenda)

For Wegovy pill based on baseline body weight of 235 lb., and for placebo based on baseline body weight of 231 lb